| Quarterly Financials | Dec 2016 | Sept 2017 | Dec 2017 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
Revenue  | 27 | 37 | 32 | 40 | 52 | 94 | 46 | 53 | 53 | 77 | 57 | 57 | 62 | 52 | 42 | 63 | 63 | 40 | 55 | 28 | 88 | 63 | 51 | 72 | 62 | 61 | 71 | 95 | 76 | 75 | 106 | 117 | 68 | 67 |
| Expenses | 26 | 32 | 28 | 32 | 39 | 82 | 38 | 44 | 45 | 63 | 48 | 47 | 51 | 44 | 38 | 50 | 50 | 36 | 48 | 24 | 73 | 56 | 45 | 60 | 56 | 53 | 67 | 88 | 79 | 69 | 102 | 102 | 64 | 64 |
| EBITDA | 2 | 5 | 4 | 9 | 13 | 12 | 8 | 9 | 8 | 14 | 9 | 11 | 11 | 8 | 4 | 12 | 13 | 4 | 7 | 3 | 16 | 6 | 7 | 13 | 7 | 8 | 4 | 7 | -4 | 7 | 4 | 15 | 4 | 3 |
| Operating Profit % | 6 % | 13 % | 13 % | 15 % | 23 % | 9 % | 10 % | 11 % | 9 % | 15 % | 13 % | 15 % | 14 % | 11 % | 6 % | 17 % | 17 % | 7 % | 8 % | 7 % | 11 % | 4 % | 12 % | 15 % | 7 % | 11 % | 1 % | 5 % | -11 % | 5 % | 2 % | 12 % | 1 % | 3 % |
| Depreciation | 1 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 4 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 4 | 4 | 3 | 3 |
| Profit Before Tax | 2 | 3 | 4 | 7 | 11 | 11 | 6 | 7 | 6 | 12 | 7 | 9 | 9 | 6 | 2 | 10 | 11 | 2 | 5 | 2 | 14 | 4 | 4 | 10 | 5 | 6 | -1 | -5 | -15 | -6 | -8 | 3 | -7 | -8 |
| Tax | 0 | 1 | 1 | 2 | 7 | 4 | 1 | 2 | 2 | 4 | 0 | 3 | 3 | 1 | 1 | 3 | 3 | 1 | 1 | 0 | 4 | 1 | 2 | 3 | 2 | 2 | 1 | 4 | 2 | 2 | 1 | 3 | 1 | 1 |
| Net Profit | 2 | 3 | 3 | 5 | 4 | 7 | 5 | 5 | 4 | 8 | 7 | 7 | 6 | 5 | 2 | 8 | 8 | 1 | 4 | 1 | 10 | 3 | 2 | 7 | 2 | 4 | -3 | -9 | -18 | -8 | -9 | -1 | -9 | -10 |
| EPS in ₹ | 2.94 | 4.62 | 5.45 | 9.15 | 7.46 | 11.34 | 9.13 | 8.29 | 7.29 | 14.11 | 12.45 | 11.58 | 11.26 | 9.46 | 3.29 | 13.49 | 13.88 | 2.32 | 7.04 | 2.03 | 17.19 | 4.94 | 4.24 | 13.03 | 6.07 | 6.45 | -0.62 | -2.11 | -27.00 | -11.42 | -14.40 | -1.00 | -12.48 | -14.03 |
Bharat Parenterals
Bharat Parenterals
1,208.00
-20.20
(-1.64%)
Market Cap
832.58 Cr
PE Ratio
-29.62
Volume
40.00
Day High - Low
1,234.35 - 1,207.00
52W High-Low
1,667.20 - 880.25
Key Fundamentals
Market Cap
832.58 Cr
EPS
-66.64
PE Ratio
-29.62
PB Ratio
2.56
Book Value
480.27
EBITDA
14.30
Dividend Yield
0.08 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
-12.88
Debt to Equity
0.64
Actual
Company News
View All News
Bharat Parenterals Gets 5 FDA Observations4 days ago
U.S. FDA conducted surprise inspection at InnoXel Lifesciences facility, issued 5 VAI observations. Company awaits final Establishment Inspection Report from regulatory authority.
Bharat Parenterals Responds to BSE Price Query
Apr 10, 2026
Apr 10, 2026Bharat Parenterals Limited clarifies to BSE that recent stock price movements are market-driven with no undisclosed material information affecting securities pricing.
Bharat Parenterals Limited publishes newspaper advertisement informing physical shareholders about special window for re-lodgement of transfer deeds under SEBI regulations.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,620.40 | #1 3,88,788.24 | 36.80 | #1 54,729.00 | 9.71 | #1 10,980 | 16.07 | 33.27 | |
6,361.50 | 1,68,877.84 | 68.31 | 9,712.00 | 18.67 | 2,191 | -1.02 | 63.24 | |
4,117.20 | 1,39,344.76 | 61.76 | 11,539.40 | 6.99 | 1,911 | 26.24 | 45.65 | |
1,317.10 | 1,09,930.83 | 20.15 | 33,741.20 | 16.73 | 5,725 | -15.28 | 61.94 | |
2,296.10 | 1,04,941.69 | 22.91 | 22,909.50 | 13.74 | 3,306 | #1 37.44 | 47.90 | |
1,295.00 | 1,04,607.60 | 23.27 | 28,409.50 | 7.12 | 5,291 | -57.18 | 60.61 | |
2,267.40 | 93,599.42 | 52.47 | 12,744.20 | #1 20.90 | 2,007 | 7.65 | 67.86 | |
927.40 | 93,318.14 | #1 18.96 | 23,511.00 | 18.55 | 4,615 | -0.32 | 55.15 | |
1,413.80 | 82,113.73 | 23.93 | 32,345.60 | 9.43 | 3,484 | 7.59 | 66.95 | |
2,299.50 | 64,892.08 | 61.93 | 13,435.50 | 6.18 | 1,047 | 15.86 | 63.32 |
Growth Rate
Revenue Growth
32.38 %
Net Income Growth
-516.19 %
Cash Flow Change
-478.56 %
ROE
-392.06 %
ROCE
-167.54 %
EBITDA Margin (Avg.)
-65.91 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 120 | 111 | 132 | 159 | 188 | 199 | 226 | 350 | 504 | 649 |
| Fixed Assets | 35 | 31 | 34 | 35 | 33 | 45 | 41 | 42 | 211 | 252 |
| Current Assets | 72 | 64 | 91 | 118 | 132 | 148 | 144 | 184 | 262 | 356 |
| Capital Work in Progress | 0 | 0 | 0 | 1 | 12 | 0 | 26 | 99 | 25 | 31 |
| Investments | 0 | 1 | 1 | 2 | 0 | 43 | 12 | 0 | 0 | 5 |
| Other Assets | 86 | 79 | 98 | 121 | 142 | 111 | 148 | 209 | 269 | 360 |
| Total Equity & Liabilities | 120 | 111 | 132 | 159 | 188 | 199 | 226 | 350 | 504 | 649 |
| Current Liabilities | 56 | 43 | 57 | 61 | 66 | 44 | 42 | 120 | 190 | 219 |
| Non Current Liabilities | 7 | 4 | 2 | 4 | 3 | 11 | 14 | 13 | 76 | 90 |
| Total Equity | 57 | 64 | 73 | 94 | 118 | 144 | 170 | 218 | 238 | 339 |
| Reserve & Surplus | 51 | 58 | 67 | 88 | 113 | 138 | 160 | 177 | 191 | 324 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 |
Cash Flow
| Cash Flow | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | -11 | 2 | 7 | -1 | -8 | 2 | 4 | 1 | -8 |
| Investing Activities | 0 | -2 | -8 | -9 | -13 | -43 | -7 | -78 | -105 | -137 |
| Operating Activities | 0 | -2 | 6 | 20 | 14 | 25 | -1 | 22 | -5 | -27 |
| Financing Activities | 0 | -8 | 4 | -4 | -3 | 11 | 9 | 61 | 110 | 156 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Oct 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 74.42 % | 74.42 % | 74.42 % | 74.42 % | 73.84 % | 73.84 % | 73.84 % | 73.84 % | 73.84 % | 73.84 % | 73.84 % | 73.84 % | 73.26 % | 73.27 % | 65.35 % | 67.20 % | 67.20 % | 67.20 % | 67.19 % | 67.19 % | 67.19 % | 67.17 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.08 % | 0.08 % | 0.11 % | 0.11 % | 0.11 % | 0.11 % | 0.11 % | 0.11 % |
| DIIs | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.57 % | 0.54 % | 0.54 % | 0.54 % | 0.54 % | 0.54 % | 0.54 % | 1.06 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 16.56 % | 16.38 % | 16.23 % | 15.46 % | 15.55 % | 15.65 % | 14.85 % | 14.70 % | 13.31 % | 13.21 % | 13.00 % | 12.99 % | 13.61 % | 13.60 % | 20.07 % | 19.00 % | 19.20 % | 18.94 % | 19.31 % | 19.27 % | 19.21 % | 18.86 % |
| Others | 9.01 % | 9.19 % | 9.34 % | 10.11 % | 10.60 % | 10.50 % | 11.30 % | 11.45 % | 12.84 % | 12.95 % | 13.15 % | 13.16 % | 13.11 % | 13.13 % | 13.92 % | 13.18 % | 12.95 % | 13.21 % | 12.85 % | 12.89 % | 12.94 % | 12.80 % |
| No of Share Holders | 0 | 2,572 | 3,122 | 2,912 | 2,805 | 2,796 | 2,765 | 2,700 | 2,515 | 2,485 | 2,481 | 2,397 | 2,497 | 2,727 | 2,748 | 2,750 | 3,116 | 3,177 | 3,231 | 3,205 | 3,172 | 3,095 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.75 | 1 | 1 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.1 | 0.11 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 25 Sept 2023 |  Dividend | ₹ 0.75 /share | 25 Sept 2023 | 328.10 | 551.50 |
| 21 May 2024 |  Extraordinary General Meeting | NA | 21 May 2024 | 1,705.95 | 1,511.15 |
| 25 Jun 2024 | Dividend | ₹ 1.00 /share | 25 Jun 2024 | 1,494.15 | 1,444.00 |
| 02 Jul 2024 |  Annual General Meeting | NA | 02 Jul 2024 | 1,409.00 | 1,500.00 |
| 29 Oct 2024 |  Quarterly Result Announcement | NA | 29 Oct 2024 | 1,440.00 | 1,355.45 |
| 03 Feb 2025 | Quarterly Result Announcement | NA | 03 Feb 2025 | 1,397.75 | 1,292.25 |
| 12 May 2025 | Quarterly Result Announcement | NA | 12 May 2025 | 987.90 | 1,089.30 |
| 28 Jul 2025 | Quarterly Result Announcement | NA | 28 Jul 2025 | 1,550.00 | 1,550.00 |
| 19 Sept 2025 | Dividend | ₹ 1.00 /share | 19 Sept 2025 | 1,089.30 | 1,319.95 |
| 26 Sept 2025 | Annual General Meeting | NA | 26 Sept 2025 | 1,355.00 | 1,300.00 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 1,222.45 | 1,097.35 |
| 30 Jan 2026 | Quarterly Result Announcement | NA | 30 Jan 2026 | 1,107.05 | 1,096.10 |
Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media Release4 days ago
4 days agoClarification On Price MovementApr 10, 2026
Apr 10, 2026Clarification sought from Bharat Parenterals LtdApr 10, 2026
Apr 10, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 08, 2026
Apr 08, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Apr 08, 2026Closure of Trading WindowMar 24, 2026
Mar 24, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2026
Feb 11, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2026
Jan 31, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 30, 2026
Jan 30, 2026Financial Results For The Quarter And Nine Months Ended On December 31 2025.Jan 30, 2026
Jan 30, 2026Board Meeting Outcome for Outcome Of Board Meeting For The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended On December 31 2025.Jan 30, 2026
Jan 30, 2026Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Month Ended On December 31 2025.Jan 22, 2026
Jan 22, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 13, 2026
Jan 13, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Jan 09, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 06, 2026
Jan 06, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 06, 2026
Jan 06, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 06, 2026
Jan 06, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJan 01, 2026
Jan 01, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 31, 2025
Dec 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 10, 2025
Dec 10, 2025Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window.Dec 09, 2025
Dec 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 04, 2025
Dec 04, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 28, 2025
Nov 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 27, 2025
Nov 27, 2025Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window.Nov 25, 2025
Nov 25, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 20, 2025
Nov 20, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Nov 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 12, 2025
Nov 12, 2025Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Nov 12, 2025
Nov 12, 2025For The Quarter And Half Year Ended September 30 2025Nov 12, 2025
Nov 12, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 12, 2025
Nov 12, 2025Board Meeting Outcome for For Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025.Nov 12, 2025
Nov 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 07, 2025
Nov 07, 2025Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended On September 30 2025.Nov 06, 2025
Nov 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Oct 09, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Sep 27, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Outcome Of AGM.Sep 26, 2025
Sep 26, 2025Intimation Of The Record Date For The Purpose Of The Dividend For FY 2024-25.Sep 10, 2025
Sep 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2025
Sep 05, 2025Intimation Under Regulation 36 Of The SEBI (LODR) Regulations 2015.Sep 04, 2025
Sep 04, 2025Intimation Of Record DateSep 04, 2025
Sep 04, 2025Intimation Of Book ClosureSep 04, 2025
Sep 04, 2025Reg. 34 (1) Annual Report.Sep 04, 2025
Sep 04, 2025Notice Of The 32Nd Annual General Meeting Of Bharat Parenterals Limited To Be Held On Friday September 26 2025.Sep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 01, 2025
Sep 01, 2025Technical Indicators
RSI(14)
Neutral 58.29
ATR(14)
Less Volatile 81.55
STOCH(9,6)
Neutral 67.72
STOCH RSI(14)
Neutral 56.85
MACD(12,26)
Bullish 7.66
ADX(14)
Weak Trend 23.58
UO(9)
Bearish 54.28
ROC(12)
Uptrend And Accelerating 9.88
WillR(14)
Neutral -28.93
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
